Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

JAMA Oncology - Tập 4 Số 3 - Trang 374 - 2018
Koji Haratani1, Hidetoshi Hayashi1, Yasutaka Chiba2, Keita Kudo3, Kimio Yonesaka1, Ryoji Kato1, Hiroyasu Kaneda1,4, Yoshikazu Hasegawa5, Kaoru Tanaka1, Masayuki Takeda1, Kazuhiko Nakagawa1
1Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan
2Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan
3Department of Medical Oncology and Respiratory Medicine, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
4Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan
5Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

JAMA Oncology

Tập 4 Số 3

374

Thông tin tác giả